HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BMSCs-derived exosomes inhibit macrophage/microglia pyroptosis by increasing autophagy through the miR-21a-5p/PELI1 axis in spinal cord injury.

Abstract
Spinal cord injury (SCI) results in a diverse range of disabilities and lacks effective treatment options. In recent years, exosomes derived from bone mesenchymal stem cells (BMSCs) have emerged as a promising cell-free therapeutic approach for treating ischemic brain injury and other inflammatory conditions. Macrophage/microglial pyroptosis has been identified as a contributing factor to neuroinflammation following SCI. The therapeutic potential of BMSC-derived exosomes in macrophage/microglia pyroptosis-induced neuroinflammation, however, has to be determined. Our findings demonstrate that exosomes derived from BMSCs can enhance motor function recovery and mitigate neuroinflammation subsequent to SCI by upregulating the expression of autophagy-related proteins and inhibiting the activation of NLRP3 inflammasomes in macrophage/microglia. Moreover, miR-21a-5p is markedly increased in BMSCs-derived exosomes, and knocking down miR-21a-5p in BMSCs-derived exosomes eliminates the beneficial effects of administration; upregulation of miR-21a-5p in BMSCs-derived exosomes enhances the beneficial effects of administration. Mechanistically, miR-21a-5p positively regulates the autophagy of macrophage/microglia by reducing PELI1 expression, which in turn inhibits their pyroptosis. This research provides novel evidence that exosomes derived from BMSCs can effectively suppress macrophage/microglia pyroptosis through the miR-21a-5p/PELI1 axis-mediated autophagy pathway, ultimately facilitating functional restoration following SCI. In particular, our constructed miR-21a-5p overexpression exosomes greatly improved the efficacy of BMSCs-derived exosomes in treating spinal cord injury. These results establish a foundation for the prospective utilization of exosomes derived from BMSCs as a novel biological intervention for spinal cord injury.
AuthorsJun Gu, Jingyi Wu, Chunming Wang, Zhenwei Xu, Zhengshuai Jin, Donghua Yan, Sheng Chen
JournalAging (Aging (Albany NY)) Vol. 16 Pg. 5184-5206 (Mar 11 2024) ISSN: 1945-4589 [Electronic] United States
PMID38466640 (Publication Type: Journal Article)
Chemical References
  • MicroRNAs
  • PELI1 protein, human
  • Nuclear Proteins
  • Ubiquitin-Protein Ligases
Topics
  • Humans
  • Microglia (metabolism)
  • Pyroptosis
  • Exosomes (metabolism)
  • Neuroinflammatory Diseases
  • Prospective Studies
  • MicroRNAs (metabolism)
  • Mesenchymal Stem Cells (metabolism)
  • Macrophages (metabolism)
  • Spinal Cord Injuries (therapy, metabolism)
  • Autophagy
  • Nuclear Proteins (metabolism)
  • Ubiquitin-Protein Ligases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: